Polypharmacy and Lipid Profiles in Type 2 Diabetes

Table 1 

Effects of Commonly Used Diabetes Agents on Lipids

(Click on table to see enlarged version)

Table 2

Effects of Commonly Used Cardiometabolic Agents on Lipids

(Click on table to see enlarged version)


Table 3

Other Agents That Can Affect Lipids 

(Click on table to see enlarged version)

ACE=angiotensin-converting enzyme; ARV=angiotensin receptor blocker; DMPA-depot medroxyprogesterone acetate; DPP-4=dipeptidyl peptidase-4; GLP-1 RA=glucagon-like peptide-1 receptor agonist; HDL-C=high-density lipoprotein cholesterol; HRT=hormone replacement therapy; LDL-C=low-density lipoprotein cholesterol; NSAID=nonsteroidal anti-inflammatory drug; PUFA-polyunsaturated fatty acid; QR=quick release; SGLT2=sodium glucose co-transporter 2; SU=sulfonylurea; TG=triglyceride; TZD=thiazolidinedione

Garber AJ, et al. Endocr Pract. 2016 Jan;22(1):84-113.

This article originally appeared on MPR